The promises of precision medicine are often heralded in the medical and lay literature, but routine integration of genomics in clinical practice is still limited. While the “last mile’ infrastructure to bring genomics to the bedside has been demonstrated in some healthcare settings, a number of challenges remain — both in the receptivity of today's health system and in its technical and educational readiness to respond to this evolution in care. To improve the impact of genomics on health and disease management, we will need to integrate both new knowledge and new care processes into existing workflows. This change will be onerous and time-consuming, but hopefully valuable to the provision of high quality, economically feasible care worldwide.
Get full access to this article
View all access options for this article.
References
1.
A.L.Wise,et al., “Genomic Medicine for Undiagnosed Diseases,”Lancet394, no. 10197 (2019): 533-540.
2.
J. F.Peterson,et al., “Electronic Health Record Design and Implementation for Pharmacogenomics: A Local Perspective,”Genetics in Medicine15, no. 10 (2013): 833-841.
3.
ACMG Board of Directors, “ACMG Policy Statement: Updated Recommendations Regarding Analysis and Reporting of Secondary Findings in Clinical Genome-Scale Sequencing,”Genetics in Medicine17, no. 1 (2015): 68-69.
4.
J. S.Roberts,et al., “Returning Individual Research Results: Development of a Cancer Genetics Education and Risk Communication Protocol,”Journal of Empirical Research in Human Research Ethics5, no. 3 (2010): 17-30.
5.
G. Q.Shaibi,et al., “Developing a Process for Returning Medically Actionable Genomic Variants to Latino Patients in a Federally Qualified Health Center,”Public Health Genomics21, no. 1-2 (2018): 77-84.
6.
C. T.Myers and H. C.Mefford, “Advancing Epilepsy Genetics in the Genomic Era,”Genome Medicine7 (2015): 91.
7.
U. S. Preventive Services Task Force, D. K.Owens,et al., “Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement,”JAMA322, no. 7 (2019): 652-665.
E. A.Balas and S. A.Boren, “Managing Clinical Knowledge for Health Care Improvement,” in J.Bemmel and A. T.McCray, eds., Yearbook of Medical Informatics 2000: Patient-Centered Systems (Stuttgart, Germany: Schattauer Verlagsgesellschaft mbH, 2000): 65-70.
10.
N. R.Anthonisen, M. A.Skeans, R. A.Wise, J.Manfreda, R. E.Kanner, J. E.Connett, and Group Lung Health Study Research, “The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality: A Randomized Clinical Trial,”Annals of Internal Medicine142, no. 4 (2005): 233-239.
11.
E. R.Park,et al., “Primary Care Provider-Delivered Smoking Cessation Interventions and Smoking Cessation among Participants in the National Lung Screening Trial,”JAMA Internal Medicine175, no. 9 (2015): 1509-1516.
12.
J. W.Timbie,et al., “Five Reasons That Many Comparative Effectiveness Studies Fail to Change Patient Care and Clinical Practice,”Health Affairs31, no. 10 (2012): 2168-2175.
13.
J. P.Ioannidis, “Why Most Published Research Findings Are False,”PLoS Medicine2, no. 8 (2005): e124.
14.
A.Donabedian, “The Quality of Care. How Can It Be Assessed?”JAMA260, no. 12 (1988): 1743-1748.
15.
L. T.Kohn, J.Corrigan, and M. S.Donaldson, To Err Is Human : Building a Safer Health System (Washington, D.C.: National Academy Press, 2000).
16.
D.Blumenthal and M.Tavenner, “The ‘Meaningful Use’ Regulation for Electronic Health Records,”New England Journal of Medicine363, no. 6 (2010): 501-504.
17.
R. A.Marmor,et al., “The Impact of Physician EHR Usage on Patient Satisfaction,”Applied Clinical Informatics9, no. 1 (2018): 11-14.
18.
D. M.Berwick, “Era 3 for Medicine and Health Care,”JAMA315, no. 13 (2016): 1329-1330.
19.
M. D.Wang, R.Khanna, and N.Najafi, “Characterizing the Source of Text in Electronic Health Record Progress Notes,”JAMA Internal Medicine177, no. 8 (2017): 1212-1213.
20.
L. N.Dyrbye,et al., “Association of Clinical Specialty with Symptoms of Burnout and Career Choice Regret among US Resident Physicians,”JAMA320, no. 11 (2018): 1114-1130.
21.
K. J.Gold, A.Sen, and T. L.Schwenk, “Details on Suicide among US Physicians: Data from the National Violent Death Reporting System,”General Hospital Psychiatry35, no. 1 (2013): 45-49.
22.
P. J.Kroth,et al., “The Electronic Elephant in the Room: Physicians and the Electronic Health Record.”Journal of the American Medical Informatics Association Open1, no. 1 (2018): 49-56.
23.
T. H.Mir,et al., “Assessing the Quality of the After-Visit Summary (AVS) in a Primary-Care Clinic,”Journal of the American Board of Family Medicine32, no. 1 (2019): 65-68.
24.
T. D.Shanafelt and J. H.Noseworthy, “Executive Leadership and Physician Well-Being: Nine Organizational Strategies to Promote Engagement and Reduce Burnout,”Mayo Clinic Proceedings92, no. 1 (2017): 129-146.
25.
R. E.Herzlinger, “Why Innovation in Healthcare Is So Hard,”Harvard Business Review84, no. 5 (2006): 58-66, 156.
26.
J. G.Palfrey and U.Gasser, Born Digital: Understanding the First Generation of Digital Natives (New York: Basic Books, 2008).
27.
J. S.Abelson,et al., “Barriers and Benefits to Using Mobile Health Technology after Operation: A Qualitative Study,”Surgery162, no. 3 (2017): 605-611.
28.
M.Rigby,et al., “Steps in Moving Evidence-Based Health Informatics from Theory to Practice,”Healthcare Informatics Research22, no. 4 (2016): 255-260.
29.
A. M.Bauer,et al., “Patient-Oriented Health Technologies: Patients' Perspectives and Use,”Journal of Mobile Technology in Medicine6, no. 2 (2017): 1-10.
30.
J. M.Pulley,et al. “Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT Project,”Clinical Pharmacology and Therapeutics92, no. 1 (2012): 87-95.
31.
D. R.Masys,et al., “Technical Desiderata for the Integration of Genomic Data into Electronic Health Records,”Journal of Biomedical Informatics45, no. 3 (2012): 419-422.
32.
D. C.Berrios, A.Beheshti, and S. V.Costes, “FAIRness and Usability for Open-Access Omics Data Systems,”American Medical Informatics Association Annual Symposium Proceedings2018 (2018): 232-241.
33.
A. E.Guttmacher, M. E.Porteous, and J. D.McInerney, “Educating Health-Care Professionals About Genetics and Genomics,”Nature Reviews Genetics8, no. 2 (2007): 151-157.
34.
B.Hurle,et al., “What Does It Mean to Be Genomically Literate? National Human Genome Research Institute Meeting Report,”Genetics in Medicine15, no. 8 (2013): 658-663.
35.
Roberts, supra note 4.
36.
J. L.Anderson,et al., “Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation,”Circulation116, no. 22 (2007): 2563-2570.
37.
A. H.Ramirez,et al., “Predicting Warfarin Dosage in European-Americans and African-Americans Using DNA Samples Linked to an Electronic Health Record,”Pharmacogenomics13, no. 4 (2012): 407-418.
38.
K. D.Christensen, D.Dukhovny, U.Siebert, and R. C.Green, “Assessing the Costs and Cost-Effectiveness of Genomic Sequencing,”Journal of Personalized Medicine5, no. 4 (2015): 470-486.
39.
E.Ammenwerth,et al., “Evaluation of Health Information Systems — Problems and Challenges,”International Journal of Medical Informatics71, no. 2-3 (2003): 125-135.
40.
B. J.Evans, “HIPAA's Individual Right of Access to Genomic Data: Reconciling Safety and Civil Rights,”American Journal of Human Genetics102, no. 1 (2018): 5-10.
41.
J.Starren, M. S.Williams, and E. P.Bottinger, “Crossing the Omic Chasm: A Time for Omic Ancillary Systems,”JAMA309, no. 12 (2013): 1237-1238.
42.
P.Starr, The Social Transformation of American Medicine (New York: Basic Books, 2017, updated ed.).
43.
H. W.Potts and J. C.Wyatt, “Survey of Doctors' Experience of Patients Using the Internet,”Journal of Medical Internet Research4, no. 1 (2002): e5.
44.
E. W.Clayton, B. J.Evans, J. W.Hazel, and M. A.Rothstein, “The Law of Genetic Privacy: Applications, Implications, and Limitations,”Journal of Law and the Biosciences (2019): 1-36.
45.
J. S.Roberts,et al., “Direct-to-Consumer Genetic Testing: User Motivations, Decision Making, and Perceived Utility of Results,”Public Health Genomics20, no. 1 (2017): 36-45.
46.
S. B.Haga, “First Responder to Genomic Information: A Guide for Primary Care Providers,”Molecular Diagnosis & Therapy23, no. 4 (2019): 459-466.
47.
Hurle, supra note 34.
48.
C. L.Overby,et al., “Opportunities for Genomic Clinical Decision Support Interventions,”Genetics in Medicine15, no. 10 (2013): 817-823.
49.
D. M.Korngiebel, S. M.Fullerton, and W.Burke, “Patient Safety in Genomic Medicine: An Exploratory Study,”Genetics in Medicine18, no. 11 (2016): 1136-1142.
50.
I. M.Lipkus, G.Samsa, and B. K.Rimer, “General Performance on a Numeracy Scale among Highly Educated Samples,”Medical Decision Making21, no. 1 (2001): 37-44.
51.
G. T.Schumock,et al., “Factors That Influence Prescribing Decisions,”Annals of Pharmacotherapy38, no. 4 (2004): 557-562.
52.
J.Bhatti and D. A.Redelmeier, “Angelina Jolie and Medical Decision Science,”Medical Decision Making35, no. 1 (2015): 4-5.
53.
D. M.Roden,et al., “Benefit of Preemptive Pharmacogenetic Information on Clinical Outcome,”Clinical Pharmacology and Therapeutics103, no. 5 (2018): 787-794.
54.
D. A.Chambers, W. G.Feero, and M. J.Khoury, “Convergence of Implementation Science, Precision Medicine, and the Learning Health Care System: A New Model for Biomedical Research,”JAMA315, no. 18 (2016): 1941-1942.
55.
A.Al Kawam,et al., “Understanding the Bioinformatics Challenges of Integrating Genomics into Healthcare,”IEEE Journal of Biomedical Health Informatics22, no. 5 (2018): 1672-1683.
